PL373670A1 - Nowe pochodne acyklicznych fosfonianów nukleozydowych, ich sole oraz sposób ich wytwarzania - Google Patents

Nowe pochodne acyklicznych fosfonianów nukleozydowych, ich sole oraz sposób ich wytwarzania

Info

Publication number
PL373670A1
PL373670A1 PL02373670A PL37367002A PL373670A1 PL 373670 A1 PL373670 A1 PL 373670A1 PL 02373670 A PL02373670 A PL 02373670A PL 37367002 A PL37367002 A PL 37367002A PL 373670 A1 PL373670 A1 PL 373670A1
Authority
PL
Poland
Prior art keywords
salts
preparation
same
acyclic nucleoside
phosphonate derivatives
Prior art date
Application number
PL02373670A
Other languages
English (en)
Other versions
PL212730B1 (pl
Inventor
Jong-Ryoo Choi
Jeong-Min Kim
Kee-Yoon Roh
Dong-Gyu Cho
Jae-Hong Lim
Jae-Taeg Hwang
Woo-Young Cho
Hyun-Sook Jang
Chang-Ho Lee
Tae-Saeng Choi
Chung-Mi Kim
Yong-Zu Kim
Tae-Kyun Kim
Seung-Joo Cho
Gyoung-Won Kim
Original Assignee
Lg Life Sciences Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Life Sciences Ltd. filed Critical Lg Life Sciences Ltd.
Publication of PL373670A1 publication Critical patent/PL373670A1/pl
Publication of PL212730B1 publication Critical patent/PL212730B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL373670A 2001-01-19 2002-01-18 Pochodne acyklicznych fosfonianów nukleozydowych oraz sposób ich wytwarzania PL212730B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20010003087 2001-01-19

Publications (2)

Publication Number Publication Date
PL373670A1 true PL373670A1 (pl) 2005-09-05
PL212730B1 PL212730B1 (pl) 2012-11-30

Family

ID=36241797

Family Applications (1)

Application Number Title Priority Date Filing Date
PL373670A PL212730B1 (pl) 2001-01-19 2002-01-18 Pochodne acyklicznych fosfonianów nukleozydowych oraz sposób ich wytwarzania

Country Status (22)

Country Link
US (3) US7157448B2 (pl)
EP (1) EP1358198B1 (pl)
JP (1) JP3959348B2 (pl)
KR (1) KR100441638B1 (pl)
CN (1) CN100347185C (pl)
AR (1) AR035933A1 (pl)
AT (1) ATE478887T1 (pl)
AU (1) AU2002230230B2 (pl)
BR (1) BR0206165A (pl)
CA (1) CA2433591C (pl)
DE (1) DE60237429D1 (pl)
DK (1) DK1358198T3 (pl)
EG (1) EG24382A (pl)
ES (1) ES2350197T3 (pl)
MX (1) MXPA03006001A (pl)
MY (1) MY141789A (pl)
NZ (1) NZ526632A (pl)
PL (1) PL212730B1 (pl)
PT (1) PT1358198E (pl)
RU (1) RU2266294C2 (pl)
WO (1) WO2002057288A1 (pl)
ZA (1) ZA200304181B (pl)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY141789A (en) * 2001-01-19 2010-06-30 Lg Chem Investment Ltd Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same.
WO2002069900A2 (en) * 2001-03-01 2002-09-12 Conforma Therapeutics Corp. Methods for treating genetically-defined proliferative disorders with hsp90 inhibitors
EP2336133A1 (en) 2001-10-30 2011-06-22 Conforma Therapeutics Corporation Purine analogs having HSP90-inhibiting activity
CA2499889A1 (en) * 2002-09-26 2004-04-08 Lg Life Sciences Ltd. (+)-trans-isomers of (1-phosphonomethoxy-2-alkylcyclopropyl) methyl nucleoside derivatives, process for the preparation of stereoisomers thereof, and use of antiviral agents thereof
EP2145888A1 (en) * 2003-09-18 2010-01-20 Conforma Therapeutics Corporation Deazapurine derivatives as HSP90-Inhibitors
KR20050062944A (ko) * 2003-12-19 2005-06-28 주식회사 엘지생명과학 디이소프로필((1-((2-아미노-6-클로로-9ｈ-퓨린-9-일)메틸)사이클로프로필)옥시)-메틸포스포네이트의 새로운 제조방법
KR20050062940A (ko) * 2003-12-19 2005-06-28 주식회사 엘지생명과학 디이소프로필((1-((2-아미노-6-할로-9ｈ-퓨린-9-일)메틸)사이클로프로필)옥시)-메틸포스포네이트의 새로운 제조방법
CN1921867B (zh) * 2004-02-17 2010-05-05 株式会社Lg生命科学 用于治疗hiv感染的膦酸核苷衍生物
KR101033290B1 (ko) * 2004-07-02 2011-05-09 주식회사 엘지생명과학 다이아이소프로필((1-(하이드록시메틸)-사이클로프로필)옥시)메틸포스포네이트의 새로운 제조 방법
EP1831235B1 (en) 2004-12-16 2013-02-20 The Regents of The University of California Lung-targeted drugs
BRPI0609509A2 (pt) 2005-03-30 2010-04-13 Conforma Therapeutics Corp composto ou um polimorfo, solvato, tautÈmero, enanciÈmero, pró-droga ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso do composto, polimorfo, solvato, tautÈmero, enanciÈmero, pró-droga ou sal farmaceuticamente aceitável
US8434912B2 (en) * 2006-02-27 2013-05-07 Illumination Management Solutions, Inc. LED device for wide beam generation
EP1994389B1 (en) * 2006-02-27 2015-06-17 Illumination Management Solutions, Inc. An improved led device for wide beam generation
GB0623493D0 (en) * 2006-11-24 2007-01-03 Univ Cardiff Chemical compounds
TWI384986B (zh) 2007-01-17 2013-02-11 Lg Life Sciences Ltd 抗病毒劑之順丁烯二酸單鹽以及含有該單鹽之醫藥組成物
EP2420238A3 (en) 2007-04-13 2012-03-07 Southern Research Institute Anti-angiogenic agents
AU2008254676B2 (en) * 2007-05-21 2012-03-22 Illumination Management Solutions, Inc. An improved LED device for wide beam generation and method of making the same
EP2326870B1 (en) * 2008-08-14 2017-01-25 Cooper Technologies Company Led devices for offset wide beam generation
WO2010065663A2 (en) * 2008-12-03 2010-06-10 Illumination Management Solutions, Inc. An led replacement lamp and a method of replacing preexisting luminaires with led lighting assemblies
CN102093422B (zh) 2009-12-10 2015-02-25 中国人民解放军军事医学科学院毒物药物研究所 无环核苷膦酸酯衍生物及其医药用途
CN102286026B (zh) * 2010-06-18 2014-07-02 中国人民解放军军事医学科学院毒物药物研究所 无环核苷酸类似物的盐及其晶型和药物组合物
BR112013014485B1 (pt) 2010-12-10 2021-03-30 Sigmapharm Laboratories, Llc Composições farmacêuticas compreendendo pró-fármacos análogos de nucleotídeos de fosfonato ativos por via oral e sistema de embalagem de recipiente/fechamento contendo as ditas composições
CN103665043B (zh) 2012-08-30 2017-11-10 江苏豪森药业集团有限公司 一种替诺福韦前药及其在医药上的应用
CN107056838A (zh) 2013-03-15 2017-08-18 加利福尼亚大学董事会 无环核苷膦酸二酯
CN104119385B (zh) * 2014-07-24 2017-04-05 廖国超 核苷类似物的磷酸酯前药及其应用
SG11201701957XA (en) 2014-09-15 2017-04-27 Univ California Nucleotide analogs
CN106432330B (zh) * 2015-08-11 2019-02-01 天津科伦药物研究有限公司 Lb80380药物的中间体化合物及其制备方法和用途
WO2017048956A1 (en) 2015-09-15 2017-03-23 The Regents Of The University Of California Nucleotide analogs
CN107849074A (zh) * 2016-01-19 2018-03-27 四川海思科制药有限公司 一种核苷类似物的烷氧烷基酯前药及其应用
CN106977548A (zh) * 2016-01-19 2017-07-25 四川海思科制药有限公司 倍司福韦复合物及其制备方法和用途
KR102623581B1 (ko) 2016-07-18 2024-01-11 일동제약(주) 항바이러스성 약물의 오로트산염, 이의 제조 방법 및 상기 염을 포함하는 약제학적 조성물
CN108276443A (zh) * 2017-01-06 2018-07-13 米文君 一种新的化合物及其用途
KR102096144B1 (ko) * 2017-07-03 2020-04-01 주식회사 엘지화학 포스포네이트 뉴클레오사이드계 b형 간염 치료제 합성용 중간체 화합물의 연속식 제조방법
CN108997429B (zh) * 2018-07-27 2020-10-30 广州粤美医药科技有限公司 一种制备贝西福韦的方法
CN113735863A (zh) * 2021-09-29 2021-12-03 武汉九州钰民医药科技有限公司 Wee1抑制剂adavosertib的制备工艺
CN113880883A (zh) * 2021-11-11 2022-01-04 奥锐特药业股份有限公司 核苷类磷酸酯前药的制备方法
CN114560463B (zh) * 2022-03-23 2023-10-20 福州大学 一种核壳结构的氮掺杂碳壳包裹碳化钼核微米球材料的制备方法
KR20250052378A (ko) 2022-07-21 2025-04-18 안티바 바이오사이언시즈, 인크. Hpv 감염 및 hpv-유도 신생물의 치료를 위한 조성물 및 투여 형태

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1494321A (en) * 1974-08-08 1977-12-07 Ici Ltd Prostanoic acid derivatives
US5688778A (en) * 1989-05-15 1997-11-18 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Nucleoside analogs
GB8922076D0 (en) 1989-09-28 1989-11-15 Beecham Group Plc Novel process
US5177104A (en) 1990-04-03 1993-01-05 E. R. Squibb & Sons, Inc. 6-α-hydroxy derivatives of mevinic acids
US5302585A (en) * 1990-04-20 1994-04-12 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Use of chiral 2-(phosphonomethoxy)propyl guanines as antiviral agents
DE69116750T2 (de) * 1990-07-04 1996-11-14 Merrell Dow Pharma 9-Purinyl-Phosphonsäurederivate
DE69129650T2 (de) * 1990-09-14 1999-03-25 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic, Prag/Praha Wirkstoffvorläufer von Phosphonaten
EP0502690B1 (en) * 1991-03-05 1999-12-01 Ajinomoto Co., Inc. Cyclopropane derivative
US5817647A (en) * 1993-04-01 1998-10-06 Merrell Pharmaceuticals Inc. Unsaturated acetylene phosphonate derivatives of purines
CA2126601A1 (en) * 1993-06-29 1994-12-30 Mitsubishi Chemical Corporation Phosphonate-nucleotide ester derivatives
KR100386685B1 (ko) * 1993-09-17 2003-12-31 길리애드 사이언시즈, 인코포레이티드 뉴클레오타이드동족체류
WO1995022330A1 (en) 1994-02-17 1995-08-24 Commonwealth Scientific And Industrial Research Organisation Antiviral agents
IT1270008B (it) 1994-09-23 1997-04-16 Ist Superiore Sanita Derivati purinici ed 8-azapurinici atti al trattamento terapeutico dell'aids
US5977061A (en) * 1995-04-21 1999-11-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic N6 - substituted nucleotide analagues and their use
US5874577A (en) * 1996-04-03 1999-02-23 Medichem Research, Inc. Method for the preparing 9-12-(Diethoxyphosphonomethoxy)ethyl!adenine and analogues thereof
US5877166A (en) * 1996-04-29 1999-03-02 Sri International Enantiomerically pure 2-aminopurine phosphonate nucleotide analogs as antiviral agents
US5922695A (en) * 1996-07-26 1999-07-13 Gilead Sciences, Inc. Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability
US5935946A (en) * 1997-07-25 1999-08-10 Gilead Sciences, Inc. Nucleotide analog composition and synthesis method
SI0988304T1 (en) 1997-08-15 2001-08-31 Medivir Ab Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv)
MY141789A (en) * 2001-01-19 2010-06-30 Lg Chem Investment Ltd Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same.
WO2004006867A2 (en) * 2002-03-15 2004-01-22 Wayne State University 2-amino-9-[(2-hydroxymethyl) cyclopropylidenemethyl] purine antiviral agents
CA2499889A1 (en) * 2002-09-26 2004-04-08 Lg Life Sciences Ltd. (+)-trans-isomers of (1-phosphonomethoxy-2-alkylcyclopropyl) methyl nucleoside derivatives, process for the preparation of stereoisomers thereof, and use of antiviral agents thereof

Also Published As

Publication number Publication date
AR035933A1 (es) 2004-07-28
AU2002230230B2 (en) 2005-05-26
KR100441638B1 (ko) 2004-07-23
RU2266294C2 (ru) 2005-12-20
PL212730B1 (pl) 2012-11-30
MXPA03006001A (es) 2003-09-10
CN100347185C (zh) 2007-11-07
US20040063668A1 (en) 2004-04-01
EP1358198A1 (en) 2003-11-05
ATE478887T1 (de) 2010-09-15
BR0206165A (pt) 2004-02-03
CN1487949A (zh) 2004-04-07
JP3959348B2 (ja) 2007-08-15
EG24382A (en) 2009-04-05
NZ526632A (en) 2005-10-28
MY141789A (en) 2010-06-30
DE60237429D1 (de) 2010-10-07
US7157448B2 (en) 2007-01-02
RU2003125372A (ru) 2005-01-20
US20100004440A1 (en) 2010-01-07
DK1358198T3 (da) 2010-10-04
EP1358198B1 (en) 2010-08-25
JP2004518675A (ja) 2004-06-24
ZA200304181B (en) 2004-10-06
EP1358198A4 (en) 2008-03-05
ES2350197T3 (es) 2011-01-20
CA2433591C (en) 2009-07-28
HK1062017A1 (en) 2004-10-15
US7605147B2 (en) 2009-10-20
US7723319B2 (en) 2010-05-25
WO2002057288A1 (en) 2002-07-25
CA2433591A1 (en) 2002-07-25
US20060293284A1 (en) 2006-12-28
PT1358198E (pt) 2010-10-01
KR20020062216A (ko) 2002-07-25

Similar Documents

Publication Publication Date Title
EP1358198A4 (en) NOVEL ACYCLIC NUCLEOSIDIC PHOSPHONATE DERIVATIVES, SALTS THEREOF AND PROCESS FOR PREPARING THE SAME
AU2003233010A8 (en) Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
HUP0401083A3 (en) 4-amino-6-phenyl-pyrrolo [2,3-d] pyrimidine derivatives, pharmaceutical compositions containing them and process for the preparation of the compounds
NO20020687D0 (no) 3(5)-ureidopyrazolderivater, fremgangsmåte for fremstilling av disse og deres anvendelse som antitumormidler
IL166710A0 (en) Process for the preparation of 4-ÄÄ4-ÄÄ-(2-cyanoethenyl)2,6-dimethylphenylÜaminoÜ-2-pyrimidinylÜaminoÜbenzonitrile
HUP0300592A3 (en) Process for the preparation of 2-halobenzoic acid derivatives
EG22992A (en) Process for the preparation of urea
HUP0202414A3 (en) Process for the preparation of perindopril, their analogous and their salts
HUP0401600A3 (en) Process for the preparation of 14-hydroxymorphine derivatives
IL143106A0 (en) Process for the preparation of acetamide derivatives
IL160043A0 (en) Process for the preparation of indole derivatives
DK1958938T3 (da) Fremgangsmåde til fremstilling af 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepin-5-carboxamid
IL156145A0 (en) Process for the preparation of phenethylamine derivatives
IL162385A0 (en) Process for the preparation of echinocandin derivatives
HUP0402475A3 (en) Process for the preparation of [1,4,5]-oxadiazepine derivatives
EP1176150A4 (en) A METHOD FOR PRODUCING TRIFLUOROTHYMIDINE DERIVATIVES
IL165137A0 (en) Process for the preparation of thioalkylamine derivatives
MXPA03006606A (es) Proceso para preparacion de analogos de indeno heterociclico.
IL162770A (en) Process for the preparation of 7??-methyl-estr-4-ene-3-one derivatives
EG22846A (en) Process for the preparation of urea
HUP0401617A3 (en) Process for the preparation of (r)- or (s)-aminocarnitine inner salt, the salts and derivatives thereof
EP1186612A4 (en) PROCESS FOR THE PREPARATION OF CYTIDIN DERIVATIVES
IL137364A (en) Process for the preparation of 6,6-dimethylhept-1-en-4-yn-3-ol
HUP0401989A3 (en) A process for the preparation of the 14 beta-hydroxy-baccatin iii-1,14-carbonate
NO20025385D0 (no) FremgangsmÕte for fremstilling av sulfonylbenzoylguanidiniumsalter

Legal Events

Date Code Title Description
RECP Rectifications of patent specification
LAPS Decisions on the lapse of the protection rights

Effective date: 20140118